HAE

Haemonetics
NYSE

Real-time Quotes | Nasdaq Last Sale

84.43
+0.28
+0.33%
After Hours: 84.43 0 0.00% 16:00 08/14 EDT
OPEN
83.96
PREV CLOSE
84.15
HIGH
84.90
LOW
83.11
VOLUME
500.70K
TURNOVER
--
52 WEEK HIGH
140.36
52 WEEK LOW
63.41
MARKET CAP
4.28B
P/E (TTM)
45.68
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average HAE stock price target is 113.67 with a high estimate of 145.00 and a low estimate of 93.00.

EPS

HAE News

More
Haemonetics Clinical Study Results On A New, Personalized Approach To Plasma Collection To Be Presented At 2020 AABB Annual Meeting
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced it will present results of its IMPACT (IMproving PlasmA CollecTion) study at the 20
PR Newswire · 08/07 10:45
Haemonetics (HAE) Q1 Earnings Beat Estimates, Margins Down
Haemonetics' (HAE) first-quarter fiscal 2021 results reflect impressive performance by Blood Center segment despite dismal overall performance during the coronavirus-led crisis.
Zacks · 08/05 13:52
Raymond James Maintains Outperform on Haemonetics, Lowers Price Target to $93
Raymond James maintains Haemonetics (NYSE:HAE) with a Outperform and lowers the price target from $113 to $93.
Benzinga · 08/05 11:29
Raymond James Maintains Outperform on Haemonetics, Lowers Price Target to $93
Raymond James maintains Haemonetics (NYSE:HAE) with a Outperform and lowers the price target from $113 to $93.
Benzinga · 08/05 11:29
Haemonetics EPS beats by $0.05, misses on revenue
Haemonetics (NYSE:HAE): Q1 Non-GAAP EPS of $0.46 beats by $0.05; GAAP EPS of $0.21 beats by $0.09. Revenue of $195.58M (-18.0% Y/Y) misses by $2.69M. Press
seekingalpha · 08/04 15:04
Haemonetics (HAE) Surpasses Q1 Earnings and Revenue Estimates
Haemonetics (HAE) delivered earnings and revenue surprises of 12.20% and 1.35%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/04 11:30
Haemonetics Q1 Adj. EPS $0.46 Beats $0.41 Estimate, Sales $196.00M Miss $198.27M Estimate
Haemonetics (NYSE:HAE) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.41 by 12.2 percent. This is a 43.21 percent decrease over earnings of $0.81 per share from the same
Benzinga · 08/04 10:14
Haemonetics First Quarter Fiscal 2021 Earnings Release Available on Investor Relations Website
Haemonetics Corporation (NYSE:HAE) announced that financial results for its first quarter fiscal 2021, which ended June 27, 2020, are available on its Investor Relations website.
PR Newswire · 08/04 10:00

Industry

Medical Equipment, Supplies & Distribution
-1.04%
Healthcare Equipment & Supplies
-1.20%

Hot Stocks

Symbol
Price
%Change

About HAE

Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company's segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection.
More

Webull offers kinds of Haemonetics Corporation stock information, including NYSE:HAE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HAE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HAE stock methods without spending real money on the virtual paper trading platform.